Dimensional Fund Advisors
BIOC

Dimensional Fund Advisors’s Biocept, Inc. BIOC Stock Holding History

Dimensional Fund Advisors’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$12K Hold
428
– – ﹤0.01% 3483
2022
Q2 		$12K Sell
428
-882
-67% -$40.2K ﹤0.01% 3456
2022
Q1 		$91K Sell
1,310
-158
-11% -$12.4K ﹤0.01% 3402
2021
Q4 		$159K Buy
+1,468
New +$169K ﹤0.01% 3376
2019
Q2 		– Sell
-212
Closed -$73K – 3481
2019
Q1 		$73K Sell
212
-156
-42% -$63.2K ﹤0.01% 3395
2018
Q4 		$95K Buy
368
+237
+181% +$119K ﹤0.01% 3362
2018
Q3 		$108K Buy
+131
New +$167K ﹤0.01% 3352

Other funds holding BIOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $783M AUM 81.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Dimensional Fund Advisors's BIOC Position: Q3 2022 in Review

Dimensional Fund Advisors held its Biocept, Inc. (BIOC) position steady in Q3 2022 at 428 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #3483.

Dimensional Fund Advisors first reported a position in BIOC in Q3 2018 and has held it in 7 quarters since. The position peaked at $159K in Q4 2021. 26 funds tracked by Wall St. Rank hold BIOC as of Q3 2022.

  • Dimensional Fund Advisors held 428 shares of Biocept, Inc. worth $12K as of Q3 2022.
  • Dimensional Fund Advisors left its Biocept, Inc. share count unchanged in Q3 2022.
  • Biocept, Inc. made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2022, its #3483 holding.
  • Dimensional Fund Advisors first reported a position in Biocept, Inc. in Q3 2018 and has held it in 7 quarters since.
  • Dimensional Fund Advisors's Biocept, Inc. position peaked at $159K in Q4 2021.
  • 26 funds tracked by Wall St. Rank held Biocept, Inc. as of Q3 2022.

Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.